Liu, Dan <br/><br/>
Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance.  [electronic resource] 

 -  Molecular immunology  Nov 2013 
 - 104-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-9142 
<br/><br/><label>Standard No.: </label>10.1016/j.molimm.2013.04.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing--genetics<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Blotting, Western<br/>Breast Neoplasms--genetics<br/>Cell Culture Techniques<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Movement--genetics<br/>Cell Survival--drug effects<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Indazoles--pharmacology<br/>MCF-7 Cells<br/>Neuregulin-1--pharmacology<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>RNA Interference<br/>Receptor, ErbB-2--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sulfonamides--pharmacology<br/>Trastuzumab